TRAW (Traws Pharma) Cyclically Adjusted Book per Share: $3.65 (As of Mar. 2026)


TRAW Traws Pharma Inc TRAW
48 GF Score
Price $0.84
GF Value $12.92
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Traws Pharma Cyclically Adjusted Book per Share?

Traws Pharma TRAW +1.24% 48 Cyclically Adjusted Book per Share is $3.65 as of Mar. 2026. GuruFocus rates TRAW with a GF Score™ of 48/100 and a GF Value™ of $12.92 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Traws Pharma's adjusted book value per share for the three months ended in Mar. 2026 was $-0.523. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.65 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Traws Pharma's average Cyclically Adjusted Book Growth Rate was -6.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Traws Pharma was -13.60% per year. The lowest was -13.60% per year. And the median was -13.60% per year.

As of today (2026-06-30), Traws Pharma's current stock price is $0.8433. Traws Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $3.65. Traws Pharma's Cyclically Adjusted PB Ratio of today is 0.23.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Traws Pharma was 38.22. The lowest was 0.23. And the median was 2.09.


Traws Pharma  (NAS:TRAW) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Traws Pharma's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.8433/3.65
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Traws Pharma was 38.22. The lowest was 0.23. And the median was 2.09.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Traws Pharma Cyclically Adjusted Book per Share Related Terms


Traws Pharma Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Traws Pharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Traws Pharma Cyclically Adjusted Book per Share Chart

Traws Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.00 5.72 7.80 3.93 3.69

Traws Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.91 3.86 3.80 3.69 3.65

TRAW vs ICU, INAB, CALC: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Traws Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Traws Pharma Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Traws Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Traws Pharma's Cyclically Adjusted PB Ratio falls into.


TRAW
48GF Score
Traws Pharma Inc TRAW
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Traws Pharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Traws Pharma's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.523/330.2130*330.2130
=-0.523

Current CPI (Mar. 2026) = 330.2130.

Traws Pharma Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 241.018 0.000
201609 9,185.000 241.428 12,562.778
201612 4,297.000 241.432 5,877.122
201703 -3,541.000 243.801 -4,796.060
201706 -194.000 244.955 -261.523
201709 -3,454.000 246.819 -4,621.021
201712 -5,845.500 246.524 -7,829.907
201803 -2,568.333 249.554 -3,398.451
201806 1,061.000 251.989 1,390.362
201809 724.000 252.439 947.057
201812 359.133 251.233 472.033
201903 -96.000 254.202 -124.706
201906 -284.125 256.143 -366.287
201909 -274.591 256.759 -353.146
201912 39.101 256.974 50.245
202003 47.865 258.115 61.235
202006 33.692 257.797 43.156
202009 24.827 260.280 31.498
202012 12.450 260.474 15.783
202103 58.880 264.877 73.404
202106 52.287 271.696 63.548
202109 59.409 274.310 71.516
202112 55.167 278.802 65.340
202203 50.583 287.504 58.097
202206 46.033 296.311 51.300
202209 39.870 296.808 44.357
202212 33.822 296.797 37.630
202303 27.266 301.836 29.829
202306 22.524 305.109 24.377
202309 17.282 307.789 18.541
202312 12.705 306.746 13.677
202403 7.135 312.332 7.543
202406 -104.269 314.175 -109.592
202409 -0.672 315.301 -0.704
202412 -8.663 315.605 -9.064
202503 1.182 319.799 1.220
202506 1.169 322.561 1.197
202509 0.637 324.800 0.648
202512 -0.069 324.054 -0.070
202603 -0.523 330.213 -0.523

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $3.65 mean?
Traws Pharma (TRAW) has a Cyclically Adjusted Book per Share of $3.65 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Traws Pharma and its competitors.
Is Traws Pharma's Cyclically Adjusted Book per Share too high?
Traws Pharma's current Cyclically Adjusted Book per Share is $3.65. Overall, Traws Pharma has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Traws Pharma's Cyclically Adjusted Book per Share compare to ICU and INAB?
Traws Pharma's Cyclically Adjusted Book per Share of $3.65 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Traws Pharma and its competitors. Traws Pharma's current Cyclically Adjusted Book per Share is $3.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Traws Pharma stock overvalued right now?
Based on GuruFocus' analysis, Traws Pharma (TRAW) is currently considered Possible Value Trap. The stock's GF Value™ is $12.92, compared to a current price of $0.84 — trading 93.5% below its estimated fair value. The current Cyclically Adjusted Book per Share is $3.65. Traws Pharma's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Traws Pharma (TRAW), the current Cyclically Adjusted Book per Share is $3.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Traws Pharma (TRAW) Overvalued in 2026?

Based on GuruFocus' analysis, Traws Pharma stock appears to be undervalued. The current stock price of $0.84 is trading 93.5% below its estimated GF Value™ of $12.92. GuruFocus considers Traws Pharma to be Possible Value Trap.

Key valuation signals for TRAW:

  • Cyclically Adjusted Book per Share: $3.65
  • GF Value™: $12.92 vs. price of $0.84 (93.5% below fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the TRAW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Traws Pharma Business Description

Address 12 Penns Trail, Newtown, PA, USA, 18940
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib. The company has four clinical programs: (i) tivoxavir marboxil, (ii) ratutrelvir, (iii) narazaciclib (ON 123300), and (iv) rigosertib. It is focused on the development of tivoxavir marboxil and ratutrelvir. The company derives revenue from its collaboration and licensing agreements.
48GF Score

Get the complete analysis for TRAW

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.84
Price
$12.92
GF Value